Rivastigmine Transdermal Patch

@article{Dhillon2011RivastigmineTP,
  title={Rivastigmine Transdermal Patch},
  author={Sohita Dhillon},
  journal={Drugs},
  year={2011},
  volume={71},
  pages={1209-1231}
}
Rivastigmine, a cholinesterase inhibitor, is available as a transdermal patch (Exelon® patch, Rivastach® patch, Prometax® patch) for the treatment of mild to moderate Alzheimer’s disease. Rivastigmine transdermal patch was effective, in terms of improving cognitive and global function, and generally well tolerated in patients with mild to moderate dementia of the Alzheimer’s type in a large, well designed trial. Most adverse events associated with rivastigmine patch were mild to moderate in… CONTINUE READING